CIMIT ModelClinical ImpactCommunity: CoLabContact Us
search
Selection Criteria


The ideal accelerator project culminates with working prototypes, identified customers who are "ready to buy", and a complete business plan that is fundable by outside parties (be they investors, established businesses or licensees).

Projects are scored based on the nine criteria below. These criteria are analyzed against objective measures, ranked 0 to 3, and then are multiplied together and scaled to provide an overall score (prefect score is 197).

CRITERIA RANK METRICS
PI's Willingness 3 Worked with CIMIT before, excited by both project and CIMIT, buys-in to accelerator vision
2
Worked with CIMIT before, likes project, is willing to go along with accelerator vision
1
New PI or has to be convinced to work with accelerator
0
Doesn't buy-in to accelerator vision
Patient Impact 3
Over 10M patients across life of project, or something that is not now curable
2
Over 1M patients
1
Over 100K patients
0
Less than 10K patients with existing cure
Market Size 3
Over $1B
2
Over $500M
1
Over $20M
0
Less than $10M
IP Position 3
Patents issued
2
Patents filed but pending
1
No or weak patents
0
No freedom to operate
Competition 3
No direct competitors
2
Competitors exist, but minimal market penetration
1
Many or entrenched competitors
0
One dominant competitor who rejects the concept
Exit Strategy 3
Licensee identified and agrees or NewCo team in place
2
Licensees or NewCos in discussions
1
No exit defined yet
0
Exit requires more money than we have
Customer Validation 3
Three or more identified who are ready to buy
2
Identified but haven't indicated a willingness to buy yet
1
None identified
0
No customers
Customer ROI 3
Less than 1 year
2
Between 1 and 3 years
1
Over 3 years
0
None
CIMIT Return 3
More than 10x investment
2
More than 5x investment
1
More than 3x investment
0
Less than 1x investment

 

CONTACT INFORMATION

Michael K. Dempsey
CIMIT Entrepreneur in Residence
and Accelerator Program Leader
mdempsey1@partners.org

Integrated Clinical EnvironmentsNeuroHealth, PTSD & TBI Industry I Foundation Engagement Homebase & Warfighter CareAccelerator

CIMIT does not rate, endorse, recommend or prescribe any products, procedures or services. Subscribe to CIMIT News in RSS


Contact the Webmaster Site Acknowledgements Copyright © 2011 CIMIT. All rights reserved. site map linking policy privacy